Ventricular Premature Contractions
Conditions
Interventions
treatment group:Treat with the oral Ziqingmanxin Dan.
control group:Administer metoprolol succinate sustained-release tablets (Betaloc). The initial dose is 23.75 mg, taken orally once daily. The dosage should be adjusted according to the patient's heart
Sponsors
Wuxi Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Traditional Chinese Medicine China
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Meets the diagnostic criteria for ventricular premature contractions in Western medicine. (2) Meets the diagnostic criteria for the syndrome of palpitations and deficiency of both qi and yin in traditional Chinese medicine. (3) Age over 18 years old. (4) No contraindications to treatment. (5) Agree to receive traditional Chinese medicine treatment orally. (6) The subjects have given informed consent and voluntarily signed the informed consent form.
Exclusion criteria
Exclusion criteria: (1) There are patients with severe critical cardiovascular emergencies such as decompensated heart failure; (2) There are patients with severe peripheral vascular diseases at risk of gangrene; (3) There are patients with severe arrhythmias, and those with clear indications for electrical cardioversion or non-drug treatment; (4) There are patients with severe liver, kidney or malignant tumors and other diseases; (5) There are patients with transient arrhythmias caused by hematological system diseases, hyperthyroidism, electrolyte imbalance or reversible factors such as drugs; (6) There are patients with a recent surgical history of less than 2 months, or those with bleeding tendencies; (7) There are women in the pregnancy, lactation or preconception period; (8) There are patients who are allergic to or have an allergic constitution to the test drug; (9) There are patients currently participating in other clinical trials of drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dynamic electrocardiogram;Traditional Chinese Medicine Syndrome Score Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Vascular endothelial growth factor;Hypoxia-inducible factor 1-alpha; | — |
Countries
China
Contacts
Public ContactGong YUJin
Wuxi Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Traditional Chinese Medicine China
Outcome results
None listed